AR and triple-negative breast carcinoma: Triple-negative breast cancers (TNBC) do not express the above three receptors and are subdivided into basal-like A and -B, mesenchymal (or claudin-low), mesenchymal stem-like, luminal androgen receptor and immunomodulatory [2, 4–7].